 SAN DIEGO SAN FRANCISCO--BUSINESS WIRE--- TCDA ClassAction--Shareholder rights law firm Robbins LLP is investigating Tricida, Inc. NASDAQ: TCDA to determine whether certain Tricida officers and directors violated the Securities Exchange Act of 1934 and breached their fiduciary duties to the Company. Tricida is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of non-absorbed therapies. Its lead drug candidate veverimer TRC101 is intended to slow the pro 